View Document Preview and Link Document Date: 2012-10-07 10:18:08 Open Document File Size: 143,84 KB Share Result on Facebook
Company Sanofi Pharma / Ranbaxy Belgium NV / Bristol-Myers Squibb / BMS France / / Country Belgium / France / United States / Netherlands / / Event Product Issues / Product Recall / / IndustryTerm generic medicinal product / reference medicinal product / i.e. healthcare professionals / healthcare professionals / drug product / reference product / generic product / test product / medicinal product / conventional manufacturing techniques / treatment of renal disease / food intake / reference products / human medicinal products / identical products / manufacturing / generic products / food interaction study / food / Manufacturing process / manufactured using conventional manufacturing techniques / / MedicalCondition hypertension / essential hypertension / nausea / C09CA04 oral essential hypertension / diabetes / CMD / fever / Aclar blister / vomiting / diabetes mellitus / diseases / renal disease / clear transparent PVC/PE/PVdC/aluminium foil blisters / transparent PVC/PE/PVdC blisters / / Organization Medicines Evaluation Board / European Pharmacopoeia Committee for Medicinal Products / European Union / European Drug Master File European Directorate for the Quality of Medicines European Union Good Clinical Practice Good Laboratory Practice Good Manufacturing Practice International Conference / / Product Irbesartan / Karvea tablets / Slovenia / Aprovel 300 mg / SUMMARY Scope / / ProgrammingLanguage EC / DC / / Technology pharmacokinetics / / URL http / SocialTag 
Microsoft Word - PAR_1242_DC_22 mar 2010.doc